Annual EBIT
$600.00M$130.70M-17.89%
Summary
- Current Value
- As of today, DXCM annual EBIT is $600.00M, down -17.89% on
- Historical Performance
- DXCM annual EBIT is up +117.71% over the past 3 years, and up +264.74% over the past 5 years
- All-Time High Comparison
- DXCM annual EBIT is currently -17.89% below its historical high of $730.70M set on
- 3-Year Low Comparison
- DXCM annual EBIT is +46.56% above its 3-year low of $409.40M reached on an earlier date
- Sector Comparison
- DXCM annual EBIT is higher than 93.40% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | $600.00M | -17.9% | +117.7% | +264.7% | +1419.3% | |
| Quarterly EBIT | $0.00 | -100.0% | -100.0% | -100.0% | +100.0% | |
| TTM EBIT | $535.20M | -14.8% | +100.9% | +80.2% | +1292.9% | |
| Price | $70.98 | -8.7% | -33.8% | -21.2% | +1771.6% | |
| PE Ratio | 39.50 | -27.6% | -69.8% | -47.1% | – | |
| Annual Revenue | $4.03B | +11.3% | +64.7% | +173.2% | +10000.0% | |
| Annual EPS | $1.42 | +9.3% | +181.5% | +420.1% | +570.7% | |
| Annual EBITDA | $600.00M | -34.5% | +58.9% | +181.4% | +1491.9% | |
| Annual Net Income | $576.20M | +6.4% | +165.7% | +469.9% | +1176.5% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $730.70M | -17.9% | |
| 5Y | $730.70M | -17.9% | |
| All | $730.70M | -17.9% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $409.40M | N/A | +46.6% |
| 5Y | $275.60M | +117.7% | |
| All | -$103.80M | +678.0% |
EBIT History
FAQ
What is the current annual EBIT of DXCM?
As of today, DXCM annual EBIT is $600.00M
What is 1-year change in DXCM annual EBIT?
DXCM annual EBIT is down -17.89% year-over-year
What is 3-year change in DXCM annual EBIT?
DXCM annual EBIT is up +117.71% over the past 3 years
How far is DXCM annual EBIT from its all-time high?
DXCM annual EBIT is currently -17.89% below its historical high of $730.70M set on December 31, 2023
How does DXCM annual EBIT rank versus sector peers?
DXCM annual EBIT is higher than 93.40% of companies in Healthcare sector
When is DXCM next annual earnings release?
The next annual earnings release for DXCM is on
Quarterly EBIT
$0.00$212.60M-100.00%
Summary
- Current Value
- As of today, DXCM quarterly EBIT is $0.00, down -100.00% on
- Historical Performance
- DXCM quarterly EBIT is down -100.00% year-over-year, and down -100.00% over the past 3 years
- All-Time High Comparison
- DXCM quarterly EBIT is currently -100.00% below its historical high of $216.90M set on
- 3-Year Low Comparison
- DXCM quarterly EBIT vs 3-year low value is unknown
- Sector Comparison
- DXCM quarterly EBIT is higher than 75.98% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual EBIT | $600.00M | – | -17.9% | +117.7% | +264.7% | |
| TTM EBIT | $535.20M | -22.1% | -14.8% | +100.9% | +80.2% | |
| Price | $70.98 | +9.0% | -8.7% | -33.8% | -21.2% | |
| PE Ratio | 39.50 | +9.0% | -27.6% | -69.8% | -47.1% | |
| Quarterly Revenue | $1.21B | +4.5% | +21.6% | +57.1% | +141.4% | |
| Quarterly EPS | $0.70 | +57.2% | +109.9% | +188.1% | +287.8% | |
| Quarterly EBITDA | $306.10M | +11.1% | +47.7% | +64.0% | +172.1% | |
| Quarterly Net Income | $283.80M | +57.8% | +110.8% | +180.4% | +293.1% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $212.60M | -100.0% | |
| 3Y | $216.90M | -100.0% | |
| 5Y | $216.90M | -100.0% | |
| All | $216.90M | -100.0% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $0.00 | N/A | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | -$164.60M | +100.0% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of DXCM?
As of today, DXCM quarterly EBIT is $0.00
What is DXCM quarterly EBIT most recent change?
DXCM quarterly EBIT was down -100.00% on September 30, 2025
What is 1-year change in DXCM quarterly EBIT?
DXCM quarterly EBIT is down -100.00% year-over-year
How far is DXCM quarterly EBIT from its all-time high?
DXCM quarterly EBIT is currently -100.00% below its historical high of $216.90M set on December 31, 2023
How does DXCM quarterly EBIT rank versus sector peers?
DXCM quarterly EBIT is higher than 75.98% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
TTM EBIT
$535.20M$152.00M-22.12%
Summary
- Current Value
- As of today, DXCM TTM EBIT is $535.20M, down -22.12% on
- Historical Performance
- DXCM TTM EBIT is down -14.78% year-over-year, and up +100.90% over the past 3 years
- All-Time High Comparison
- DXCM TTM EBIT is currently -22.12% below its historical high of $687.20M set on
- 3-Year Low Comparison
- DXCM TTM EBIT is +36.81% above its 3-year low of $391.20M reached on an earlier date
- Sector Comparison
- DXCM TTM EBIT is higher than 92.32% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $535.20M | -22.1% | -14.8% | +100.9% | +80.2% | |
| Annual EBIT | $600.00M | – | -17.9% | +117.7% | +264.7% | |
| Quarterly EBIT | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Price | $70.98 | +9.0% | -8.7% | -33.8% | -21.2% | |
| PE Ratio | 39.50 | +9.0% | -27.6% | -69.8% | -47.1% | |
| TTM Revenue | $4.52B | +5.0% | +14.2% | +61.7% | +148.0% | |
| TTM EPS | $1.80 | +25.8% | +7.7% | +205.3% | +197.8% | |
| TTM EBITDA | $1.02B | +10.7% | +21.6% | +144.5% | +185.5% | |
| TTM Net Income | $720.70M | +26.1% | +5.9% | +195.3% | +211.9% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $687.20M | -22.1% | |
| 3Y | $687.20M | -22.1% | |
| 5Y | $687.20M | -22.1% | |
| All | $687.20M | -22.1% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $535.20M | at low | |
| 3Y | $391.20M | N/A | +36.8% |
| 5Y | $237.20M | +125.6% | |
| All | -$186.30M | +387.3% |
TTM EBIT History
FAQ
What is the current TTM EBIT of DXCM?
As of today, DXCM TTM EBIT is $535.20M
What is DXCM TTM EBIT most recent change?
DXCM TTM EBIT was down -22.12% on September 30, 2025
What is 1-year change in DXCM TTM EBIT?
DXCM TTM EBIT is down -14.78% year-over-year
How far is DXCM TTM EBIT from its all-time high?
DXCM TTM EBIT is currently -22.12% below its historical high of $687.20M set on June 30, 2025
How does DXCM TTM EBIT rank versus sector peers?
DXCM TTM EBIT is higher than 92.32% of companies in Healthcare sector
When is DXCM next earnings release?
The next earnings release for DXCM is on
EBIT Formula
EBIT = Revenue − −
Data Sources & References
- DXCM Official Website www.dexcom.com/global
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1093557/000109355725000280/0001093557-25-000280-index.htm
- DXCM Profile on Yahoo Finance finance.yahoo.com/quote/DXCM
- DXCM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dxcm